Molecular Pathology of Skin Melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy Prediction
出版年份 2022 全文链接
标题
Molecular Pathology of Skin Melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy Prediction
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 10, Pages 5384
出版商
MDPI AG
发表日期
2022-05-12
DOI
10.3390/ijms23105384
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Prognostic Significance of Primary Tumor-Infiltrating Lymphocytes in a Contemporary Melanoma Cohort
- (2022) Richard J. Straker et al. ANNALS OF SURGICAL ONCOLOGY
- Promising Blood-Based Biomarkers for Melanoma: Recent Progress of Liquid Biopsy and Its Future Perspectives
- (2022) Hisashi Kanemaru et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Identification of a Tumor Cell Associated Type I IFN Resistance Gene Expression Signature of Human Melanoma, the Components of Which Have a Predictive Potential for Immunotherapy
- (2022) Andrea Ladányi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1
- (2022) John A. McCulloch et al. NATURE MEDICINE
- Melanomas with concurrent BRAF non-p.V600 and NF1 loss-of-function mutations are targetable by BRAF/MEK inhibitor combination therapy
- (2022) Shivshankari Rajkumar et al. Cell Reports
- Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response
- (2021) Fabio Valenti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects
- (2021) Dekker C. Deacon et al. Frontiers in Medicine
- TMB or not TMB as a biomarker: That is the question
- (2021) Alfredo Addeo et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Histological regression in melanoma: impact on sentinel lymph node status and survival
- (2021) Karina Aivazian et al. MODERN PATHOLOGY
- Construction and Validation of a Novel Immunosignature for Overall Survival in Uveal Melanoma
- (2021) Chufeng Gu et al. Frontiers in Cell and Developmental Biology
- Organ Specific Copy Number Variations in Visceral Metastases of Human Melanoma
- (2021) Orsolya Papp et al. Cancers
- Metabolic Plasticity in Melanoma Progression and Response to Oncogene Targeted Therapies
- (2021) Arwa Alkaraki et al. Cancers
- Tertiary lymphoid structures improve immunotherapy and survival in melanoma
- (2020) Rita Cabrita et al. NATURE
- Systemic Therapy for Melanoma: ASCO Guideline
- (2020) Rahul Seth et al. JOURNAL OF CLINICAL ONCOLOGY
- Uveal melanoma
- (2020) Martine J. Jager et al. Nature Reviews Disease Primers
- Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response
- (2020) Jessica Roelands et al. Journal for ImmunoTherapy of Cancer
- The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma
- (2020) Yijie Wang et al. EXPERIMENTAL EYE RESEARCH
- Role of the anatomic site in the association of HLA class I antigen expression level in metastases with clinical response to ipilimumab therapy in patients with melanoma
- (2020) Andrea Ladányi et al. Journal for ImmunoTherapy of Cancer
- Genetic and Environmental Determinants of Immune Response to Cutaneous Melanoma
- (2019) Joanna Poźniak et al. CANCER RESEARCH
- Immunologic and immunogenomic aspects of tumor progression
- (2019) Andrea Ladányi et al. SEMINARS IN CANCER BIOLOGY
- Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
- (2019) David Liu et al. NATURE MEDICINE
- KIT Mutation Incidence and Pattern of Melanoma in Central Europe
- (2019) V. Doma et al. PATHOLOGY & ONCOLOGY RESEARCH
- The role of lipid signaling in the progression of malignant melanoma
- (2018) József Tímár et al. CANCER AND METASTASIS REVIEWS
- Defective HLA class I antigen processing machinery in cancer
- (2018) Lei Cai et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade
- (2018) Sachet A. Shukla et al. CELL
- Comparison of melanoma gene expression score with histopathology, fluorescence in situ hybridization, and SNP array for the classification of melanocytic neoplasms
- (2018) Julie D. R. Reimann et al. MODERN PATHOLOGY
- Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment—A Review From the Melanoma Perspective and Beyond
- (2018) Kristina Buder-Bakhaya et al. Frontiers in Immunology
- Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)
- (2018) Patrick Danaher et al. Journal for ImmunoTherapy of Cancer
- A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis
- (2018) Yanding Zhao et al. MOLECULAR CANCER RESEARCH
- Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
- (2018) Tímea Balatoni et al. PATHOLOGY & ONCOLOGY RESEARCH
- Melanoma subtypes: Genomic profiles, prognostic molecular markers and therapeutic possibilities
- (2018) Roy Rabbie et al. JOURNAL OF PATHOLOGY
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients
- (2017) Hojabr Kakavand et al. MODERN PATHOLOGY
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resistance to checkpoint blockade therapy through inactivation of antigen presentation
- (2017) Moshe Sade-Feldman et al. Nature Communications
- Genomic Analysis of Tumor Microenvironment Immune Types across 14 Solid Cancer Types: Immunotherapeutic Implications
- (2017) Yu-Pei Chen et al. Theranostics
- An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi
- (2016) Loren E. Clarke et al. CANCER
- Genetic progression of malignant melanoma
- (2016) J. Tímár et al. CANCER AND METASTASIS REVIEWS
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
- (2016) Jianjun Gao et al. CELL
- Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy
- (2016) Nadeem Riaz et al. NATURE GENETICS
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- The genomic landscape of cutaneous melanoma
- (2016) Tongwu Zhang et al. Pigment Cell & Melanoma Research
- Density of immunogenic antigens does not explain the presence or absence of the T-cell–inflamed tumor microenvironment in melanoma
- (2016) Stefani Spranger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetic alterations in fatty acid transport and metabolism genes are associated with metastatic progression and poor prognosis of human cancers
- (2016) Aritro Nath et al. Scientific Reports
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- A p16-Ki-67-HMB45 immunohistochemistry scoring system as an ancillary diagnostic tool in the diagnosis of melanoma
- (2015) Arnaud Uguen et al. Diagnostic Pathology
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma
- (2015) Andrea Ladányi Pigment Cell & Melanoma Research
- Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
- (2015) W. Peng et al. Cancer Discovery
- Dissection of Immune Gene Networks in Primary Melanoma Tumors Critical for Antitumor Surveillance of Patients with Stage II–III Resectable Disease
- (2014) Shanthi Sivendran et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update
- (2013) Nelson G. Ordóñez HUMAN PATHOLOGY
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma
- (2012) G. Erdag et al. CANCER RESEARCH
- Uveal Melanoma: The Inflammatory Microenvironment
- (2012) Inge H.G. Bronkhorst et al. Journal of Innate Immunity
- Melanoma Genetics: Recent Findings Take Us Beyond Well-Traveled Pathways
- (2012) Matthew H. Law et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Genome-wide association study identifies novel loci predisposing to cutaneous melanoma†
- (2011) Christopher I. Amos et al. HUMAN MOLECULAR GENETICS
- Genome-wide association study identifies three new melanoma susceptibility loci
- (2011) Jennifer H Barrett et al. NATURE GENETICS
- The Queensland Study of Melanoma: Environmental and Genetic Associations (Q-MEGA); Study Design, Baseline Characteristics, and Repeatability of Phenotype and Sun Exposure Measures
- (2008) Amanda J. Baxter et al. Twin Research and Human Genetics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More